Soliscribe
A self-serve AI contracting-officer copilot that turns a rough scope of work into a complete, bid-protest-defensible solicitation package, billed per solicitation instead of by enterprise contract.
A contracting officer at a county procurement office has a scope of work and a deadline, and no realistic way to buy software to help. The enterprise tools that exist start at agency-wide contracts and sales calls — too big, too slow, and impossible to put on a purchasing card. So the package gets assembled by hand from old templates: the solicitation document, the evaluation criteria, the compliance matrix, the scoring template that has to survive a bid protest. It is slow, error-prone, and the institutional knowledge lives in whoever did it last.
The contracting officer (or procurement lead) at a state, county, or municipal procurement office — the person who owns producing a defensible solicitation package and personally absorbs the time when there is no tool to help.
A contracting officer at a municipal or county procurement office, billed per solicitation below procurement thresholds so it's card-purchasable, replacing manual templates — crisp enough to write the sales email.
Self-serve, per-solicitation document generation over a verified generation substrate — transactional, pure SaaS.
Four cross-references, thirteen inbound, three connections — moderate, and mostly within its own run rather than spanning the wider graph.
A crisp, transactional buyer with a price point engineered below procurement thresholds, a named enterprise-only competitive field with VC validation of the 90,000-entity market, and a verified document-generation substrate — the leverage and buyer are the strengths.
Convergence is moderate and mostly in-run, there is no hard dated mandate forcing the timing, two of the run's signals carry unknown provenance, and the self-serve-government thesis — though plausible — is behaviorally unproven.
Genesis doesn't invent in isolation — Soliscribe shares architecture with, or powers, these ideas.
Discussion
No comments yet — be the first to weigh in.